Cita APA

Bunaciu, R. P., MacDonald, R. J., Jensen, H. A., Gao, F., Wang, X., Johnson, L., . . . Yen, A. (2018). Retinoic acid and 6-formylindolo(3,2–b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML. Leuk Lymphoma.

Citación estilo Chicago

Bunaciu, Rodica P., Robert J. MacDonald, Holly A. Jensen, Feng Gao, Xin Wang, Lynn Johnson, Jeffrey D. Varner, and Andrew Yen. "Retinoic Acid and 6-formylindolo(3,2–b)carbazole (FICZ) Combination Therapy Reveals Putative Targets for Enhancing Response in Non-APL AML." Leuk Lymphoma 2018.

Cita MLA

Bunaciu, Rodica P., et al. "Retinoic Acid and 6-formylindolo(3,2–b)carbazole (FICZ) Combination Therapy Reveals Putative Targets for Enhancing Response in Non-APL AML." Leuk Lymphoma 2018.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.